IMDX
Insight Molecular Diagnostics Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.00
+1.27%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.24
- Revenue estimate
- $215.1K
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$0.31
- EPS estimate
- -$0.25
- Revenue actual
- $239.0K
- Revenue estimate
- $437.5K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +42.2%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $8.50
- PT range
- $8.00 – $9.00
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.25 | -$0.31 | Miss -22.07% | $239.0K |
| May 13, 2026 | -$0.26 | -$0.28 | Miss -7.07% | $32.0K |
| Mar 26, 2026 | -$0.24 | -$0.27 | Miss -13.68% | $1.1M |
| Mar 24, 2025 | -$0.43 | $0.48 | Beat 211.63% | $1.5M |
| Aug 8, 2024 | -$0.56 | -$0.36 | Beat 35.71% | $104.0K |
| May 15, 2024 | -$0.67 | -$1.13 | Miss -68.66% | $176.0K |
| Mar 29, 2024 | -$1.57 | -$1.94 | Miss -23.30% | $314.0K |
| Nov 9, 2023 | -$1.52 | -$0.57 | Beat 62.50% | $429.0K |
| Aug 10, 2023 | -$2.60 | -$1.07 | Beat 58.85% | $463.0K |
| May 11, 2023 | -$2.40 | -$0.80 | Beat 66.67% | $297.0K |
| Nov 10, 2022 | -$2.60 | -$1.60 | Beat 38.46% | $1.0M |
| Aug 10, 2022 | -$2.60 | -$1.40 | Beat 46.15% | $2.1M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026